Industry Responds to FDA’s Quality Metrics Initiative with Proposal to Report Trends, not Values
This article was originally published in The Gold Sheet
Industry, FDA explore why manufacturers should report absolute value of quality metrics, not just the trends. FDA’s Woodcock suggests potential reward of reduced inspections by not only FDA, but also by other inspectorates.
You may also be interested in...
Cynthia Schnedar decides to leave several weeks after FDA determined that her husband's promotion could create conflicts of interest.
CDER’s Woodcock says the new database will drive risk-based inspection decisions.
Remediation must be quick and sure, say FDA’s Woodcock and Marks, despite challenges with facilities, equipment, processes and personnel training.